(Q36810118)

English

Age disparity between a cancer population and participants in clinical trials submitted as a new drug application of anticancer drugs in Japan

scientific article published on June 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

0 references

Age disparity between a cancer population and participants in clinical trials submitted as a new drug application of anticancer drugs in Japan (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

author name string

Akiko Hori

1

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Taro Shibata

2

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Masahiro Kami

3

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Eiji Kusumi

4

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Hiroto Narimatsu

5

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Yukiko Kishi

6

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Naoko Murashige

7

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Kazuhiko Mori

8

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

language of work or name

0 references

publication date

1 June 2007

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

109

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

2541-2546

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22721

7 January 2021

based on heuristic

inferred from DOI database lookup

Underrepresentation of patients 65 years of age or older in cancer-treatment trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22721

7 January 2021

based on heuristic

inferred from DOI database lookup

Participation of patients 65 years of age or older in cancer clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22721

7 January 2021

based on heuristic

inferred from DOI database lookup

Enrollment of Older Patients in Cancer Treatment Trials in Canada: Why is Age a Barrier?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22721

7 January 2021

based on heuristic

inferred from DOI database lookup

Aging and pharmacology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22721

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug therapy in the elderly: what doctors believe and patients actually do

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22721

7 January 2021

based on heuristic

inferred from DOI database lookup

Fatal hyalohyphomycosis following Fusarium onychomycosis in an immunocompromised patient.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22721

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunohistochemical identification of Penicillium marneffei by monoclonal antibody

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22721

7 January 2021

based on heuristic

inferred from DOI database lookup

The advisory process for anticancer drug regulation: a global perspective

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22721

7 January 2021

based on heuristic

inferred from DOI database lookup

Systematic review of barriers to the recruitment of older patients with cancer onto clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22721

7 January 2021

based on heuristic

inferred from DOI database lookup

Goserelin versus orchiectomy in the treatment of advanced prostate cancer: final results of a randomized trial. Zoladex Prostate Study Group.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22721

7 January 2021

based on heuristic

inferred from DOI database lookup

Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women: results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22721

7 January 2021

based on heuristic

inferred from DOI database lookup

IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22721

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22721

7 January 2021

based on heuristic

inferred from DOI database lookup

Severe acute interstitial pneumonia and gefitinib

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22721

7 January 2021

based on heuristic

inferred from DOI database lookup

London's disastrous drug trial has serious side effects for research

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22721

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.22721

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36810118&oldid=2112620263"